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Predictors of Quality of Life Ratings from Persons with Dementia:  
The role of insight 
 
 
 
Abstract 
 
Objective Evidence suggests that people with dementia are able to 
respond accurately and consistently to questions about quality of life 
(QoL), although large discrepancies exist between patient and proxy 
ratings. This may be due, in part, to the reduced insight of the person 
with dementia. The aim of this study was to explore the predictors of QoL 
ratings in a sample of people with mild dementia, with a particular focus 
on the role of insight.  
Methods Sixty-nine participants and their caregivers were recruited from 
a memory clinic setting. The Bath Assessment of Subjective Quality of Life 
in Dementia (BASQID), Alzheimer’s Disease-Related Quality of Life Scale, 
Memory Functioning Scale, Alzheimer's Disease Cooperative Study 
Activities of Daily Living (ADL) Inventory and Mini Mental Status 
Examination were administered.  
Results Regression analyses indicated that the strongest predictor of QoL 
ratings from persons with dementia was their awareness of memory 
function, such that lower awareness was associated with higher QoL 
ratings. Proxy ratings of activity performance and enjoyment of activity 
were also significant predictors of BASQID scores.  
Conclusions Awareness of memory function impacts directly on patient 
QoL ratings and can also mask the effects of changes in other outcomes 
such as ADL function. Measures of awareness should therefore be 
employed alongside patient QoL ratings in order to ensure they are 
interpreted accurately. Discrepancies between patient and proxy QoL 
ratings do not necessarily occur because of patient unreliability, but may 
instead reflect the application of distinct modes of QoL assessment that 
emphasise very different outcomes. 
 3 
 
KEYWORDS:  
Dementia; Quality of Life; Insight; Awareness; BASQID; Self-Report  
 
Introduction 
 
Dementia imposes a significant burden on patients and their families and 
remains a major issue for health and social services (Ferri et al., 2005). 
Achieving a full understanding of the impact of dementia, and the 
effectiveness of various therapies and interventions, is a complex task 
requiring both objective assessments of memory and function as well as 
attention to the subjective experiences, values and perspectives of the 
patient (Kitwood, 1995; Whitehouse, 1999). Quality of life (QoL) 
measures become an important resource in this context, offering valuable 
information about the impact of dementia on a person’s life. 
 
It has been argued that first-person evaluations of life quality are central 
to the measurement of QoL (The WHOQOL Group, 1995). This has led to a 
growth in the number of dementia-specific QoL assessments which elicit 
ratings directly from the person with dementia (Brod et al., 1999; Selai et 
al., 2001; Logsdon et al., 2002; Ready et al., 2002; Smith et al., 2007; 
Trigg et al., 2007b). Yet the reliability of patient ratings remains a matter 
for debate. Cognitive impairment and the apparent lack of insight 
demonstrated by many individuals with dementia are often cited as 
arguments against an over-reliance on patient QoL reports (Rabins et al., 
1999). As a result, first-person evaluations tend to be employed only as a 
supplement to the third-person ratings provided by a caregiver or 
alternative proxy (see Ettema et al., 2005 for review).  
 
The first of these arguments can be challenged. In the context of mild to 
moderate dementia, a growing body of evidence suggests that general 
cognitive impairment does not stop patients providing consistent and 
reliable responses to questions about QoL (Brod et al., 1999; Feinberg 
and Whitlach, 2001; Logsdon et al., 2002; Trigg et al., 2007a). There is, 
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however, very little empirical evidence relating to the impact of insight on 
the validity of QoL judgements.  
 
Lack of insight refers to a range of phenomena whereby people with 
dementia lack awareness (Aalten et al., 2005) in relation to specific 
cognitive deficits (anosognosia), social functioning, behaviour, or general 
life circumstances. It has been argued that if a dementia patient is not 
fully aware of the disease “how can we believe a patient’s assessment of 
the impact of the disease on QoL?” (Whitehouse, 1999, p108). These 
doubts seem to be further justified by significant discrepancies in the QoL 
ratings provided by patients and their proxies. The association between 
caregiver and patient ratings appears to be weak or moderate at best 
(Logsdon et al., 2002; Novella et al., 2001). A general pattern emerges in 
which the proxies judge the patient’s QoL to be lower than the patients 
themselves and the unreliability of patient data appears to be confirmed.     
 
Such conclusions must nonetheless be drawn with caution. Insight has a 
complex and multidimensional impact in dementia (Howarth and Saper, 
2003) and awareness varies greatly amongst individuals and across a 
range of domains, such as self-care, memory, health status and language 
abilities (Green et al., 1993; Vasterling et al., 1995). To assume a direct 
connection between lack of insight and the unreliability of patient QoL 
evaluations is therefore problematic. Indeed, Brod et al. (1999) have 
argued that awareness of feeling states is distinct from awareness of 
cognitive and functional performance. This suggests a patient’s ability to 
report on how they feel about their QoL may be preserved even in cases 
where awareness of dementia is very limited.  
 
Recent research has focussed on ascertaining the key determinants of 
self-report patient QoL ratings. This is important, if the meaning and 
significance of such ratings is to be grasped. Selai et al. (2001) found 
significant associations between QoL and social activities, dementia 
severity and neuropsychiatric symptoms, whilst Logsdon et al. (2002) also 
noted the impact of depression (see also Hoe et al., 2006; 2007) and 
pleasant activities. Ready et al. (2004) examined predictors of patient 
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scores on the Dementia Quality of Life scale (DQOL; Brod et al., 1999) 
and found neuropsychiatric symptoms (including agitation, depression and 
anxiety) to be the only significant predictors of global QoL. Activities of 
daily living scores failed to significantly predict QoL in this study (see also 
Hoe et al., 2007; Logsdon et al., 2002), as did scores for the Mini Mental 
State Examination (MMSE). A comprehensive review of this literature is 
provided by Banerjee et al. (2009). Interestingly, Ready et al. (2004) and 
Vogel et al. (2006) found no significant association between insight and 
QoL ratings. In a recent study, Hurt et al. (2009), found insight not to be 
related to QoL in patients with mild dementia, however found insight 
alone to be the sole predictor of QoL within moderate dementia. There is 
clearly a need for further investigation of the impact of insight on QoL 
ratings from cognitively impaired populations (Ready et al., 2004 Hurt et 
al., 2009). 
 
The current paper explores these issues through the analysis of baseline 
data drawn from an ongoing 3-year longitudinal study designed to 
examine subjective QoL changes in people with early-stage dementia. 
These initial analyses focus on the main predictors of patient QoL ratings, 
with a particular emphasis on the role of insight as well as observable 
indices of function, behaviour and affect. The overall aim is to better 
understand the factors that influence QoL evaluations in people with mild 
dementia and, in so doing, to facilitate their interpretation.  
 
Method 
 
Participants 
The sample included 69 people diagnosed with dementia according to DSM 
criteria (DSM-IV-TR; American Psychiatric Association, 2000) and their 
caregivers. Patients were recruited from a memory clinic setting and all 
had mild-stage dementia (an MMSE score of 18 or more; Tombaugh et al., 
1992) at the time of recruitment. A purposive sampling strategy was 
employed to include patients with a range of demographic characteristics 
such as type of dementia, age and living arrangements. Table 1 (below) 
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provides a full demographic summary of the sample. Ethical approval was 
obtained from the National Health Service Research Ethics Committee. 
 
INSERT TABLE 1 HERE 
 
Materials 
The Bath Assessment of Subjective Quality of Life in Dementia  
(BASQID; Trigg et al., 2007b) 
 
The BASQID is a 14-item measure eliciting subjective QoL information 
direct from people with mild to moderate dementia. It can be scored as a 
single scale or as two subscales which assess life satisfaction (LS) and 
feelings of positive life quality (FPQ). Responses are transformed to give 
scores ranging from 0-100, with higher scores indicative of a better QoL. 
The BASQID and its subscales demonstrate good reproducibility, internal 
consistency and construct validity (Trigg et al., 2007b) and the measure 
exhibits moderate and low to moderate associations with the GDS-15 (15-
item Geriatric Depression Scale) and the proxy completed WHOQOL-BREF 
respectively.  
 
Memory Functioning Scale  
(MARS-MFS; Clare et al., 2002) 
 
The MARS-MFS is a 13-item subscale of the Memory Awareness Rating 
Scale (MARS) which captures subjective views of memory functioning. It 
is administered to both the person with dementia and their caregiver and 
assesses the patient’s capacity to ‘manage’ across a range of everyday 
memory situations. Scores range from 0-52 with higher scores indicating 
better memory function. Discrepancy scores (obtained by subtracting the 
caregiver’s rating from the patient’s) assess the patient’s awareness of 
memory. A positive discrepancy value indicates that the patient has some 
lack of insight in relation to their memory function. The MARS-MFS has 
good internal consistency, reproducibility and criterion validity, the latter 
having been established in relation to both the Memory Insight and 
Memory Symptoms questionnaires (Clare et al., 2002). 
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Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory 
(ADCS-ADL; Galasko et al., 1997) 
 
The ADCS-ADL contains 23 questions about basic and instrumental 
activities of daily living (ADL and IADL). The questions all require an 
informant to provide a current assessment of the patient's capacity to 
perform particular daily activities. Total scores for the scale range from 0-
78, with higher scores indicating independent performance. Test-retest 
reliability of the ADCS-ADL is good and the measure has demonstrated 
sensitivity to disease progression (Galasko et al., 1997). 
 
Alzheimer’s Disease-Related Quality of Life Scale (ADRQL; Rabins et al., 
1999)  
 
The ADRQL is a measure of patient health-related QoL that is usually 
administered to a caregiver. The scale contains 47 true or false items 
divided into five subscales: Social Interaction, Awareness of Self, Feelings 
and Mood, Enjoyment of Activities, and Response to Surroundings. Each 
subscale can be scored separately or combined to give a total score for 
QoL. Scale scores are determined using a preference-based weighting 
approach, where weights for QoL indicators differ according to pre-
determined ratings of importance. Scores for each subscale range from 0-
100, with higher scores indicating a better QoL. The ADRQL demonstrates 
good internal consistency for the scale and subscales (Black et al., 2000) 
and has shown concurrent validity (Gonzalez-Salvador et al., 2000).  
 
Mini Mental State Examination (MMSE; Folstein et al., 1975) 
 
The MMSE is a widely used measure of cognitive function, with a 
maximum score of 30 points. It assesses aspects of orientation to time 
and place, registration, attention, calculation, recall, language, and visual 
construction. Higher scores indicate better cognitive function. MMSE 
scores can validly discriminate between people with dementia, depression, 
or cognitive impairment with depression (Folstein et al., 1975). The 
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measure has demonstrated good test-retest and inter-rater reliability and 
has been extensively validated (Tombaugh & McIntyre, 1992). 
 
Procedure 
Written informed consent was obtained from both patient and caregiver 
and assessments were administered in the patient’s home. The patient 
completed the BASQID, MMSE and MARS-MFS, whilst the ADRQL, ACDS-
ADL and MARS-MFS were completed by the caregiver. Patients and 
caregivers were kept apart during scale completion to eliminate the 
possibility of mutual influence.  
 
Analysis 
Descriptive statistics for all scales were calculated and bivariate 
associations between the main study variables were explored using 
Spearman correlation coefficients. Due to multiple univariate analyses we 
used p < 0.01 level for significance. Stepwise hierarchical multiple 
regression was used to determine predictors of self-report QoL ratings. 
Given the exploratory nature of this analysis, all scale data was initially 
entered into the regression. In a second step, moderator analysis was 
used to explore possible interactions between significant predictors in the 
model. Internal consistency of BASQID scores was explored using 
Cronbach’s alpha across high and low insight groups. 
 
Results 
 
All respondents were able to complete the assessments. Missing data was 
only recorded for one question in the carer-completed ADRQL (Table 2). 
Mean score on the BASQID was 60.38 (SD = 14.49) with values for the 
25% and 75% quartiles of 50 and 70 respectively. In all but four cases, 
discrepancy scores on the MARS-MFS were positive, indicating reduced 
insight in the person with dementia. The distribution of scores on the 
ADRQL total and subscales displayed a clear negative skew, with median 
values within the range 77-88 for all scales except Enjoyment of Activities.  
 
INSERT TABLE 2 HERE 
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Stage 1 Analyses 
Spearman correlation coefficients (Table 3) indicated that the association 
between patient QoL scores, measured by the BASQID total score, and 
the caregiver ratings of patient QoL, captured by the ADRQL total score, 
was not significant (r = 0.23, p >0.01). The strongest associations were 
found between BASQID scores and scores on the Social Interaction and 
Enjoyment of Activities subscales of the ADRQL (r = 0.33, p < 0.01; r = 
0.32, p < 0.01) and MARS-MFS discrepancy scores (r = 0.31, p < 0.01), 
which are indicative of the patient’s level of insight in relation to their own 
memory function. The MMSE measure of cognitive function failed to show 
any significant association with total scores on either the BASQID (r = 
0.05, p > 0.01) or the ADRQL total (r = 0.20, p > 0.01). Interestingly, 
MARS-MFS discrepancy scores did not correlate significantly with any of 
the proxy ratings of QoL or with MMSE scores. However, they did show a 
moderate correlation with ADCS-ADL scores (r = -0.45, p < 0.01) and 
hence with activities of daily living performance. ADCS-ADL scores also 
demonstrated a significant correlation with the Enjoyment of Activities 
subscale of the ADRQL (r = 0.36, p < 0.01).  
 
No demographic variables were related to BASQID scores, inasmuch as no 
significant difference was observed between the QoL ratings of men and 
women (t = 0.57, p > 0.01) and QoL ratings showed no significant 
association with age (r = -0.07, p > 0.01). 
 
INSERT TABLE 3 HERE 
 
Stage 2 Analyses 
Three stepwise hierarchical linear regressions were used to determine the 
independent predictors of patient QoL scores on the BASQID and its two 
subscales (LS and FPQ). In the first step, scores on the ADCS-ADL and 
MMSE, discrepancy scores from the MARS-MFS and the five subscales of 
the ADRQL were entered into the model. For the BASQID total score, LS 
and FPQ subscales, only ADQRL Enjoyment of Activities, ADCS-ADL and 
MARS-MFS discrepancy scores were significant predictors (Table 4). For 
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each of the three models, MARS-MFS discrepancy scores were the 
strongest predictor with ADCS-ADL scores the second strongest. This 
means that higher patient QoL ratings were best predicted by lower levels 
of patient insight in relation to their own memory function, better ADL 
performance and increased enjoyment of activities. 
 
INSERT TABLE 4 HERE 
 
As a second step, we entered two interaction terms (MARS-MFS x ADCS-
ADL and MARS-MFS x ADRQL Enjoyment of Activities) to explore the 
possibility that insight might act as a moderator in the relationships 
between patients’ QoL ratings and scores on the ADCS-ADL and ADQRL 
Enjoyment of Activities scales. Scores on the predictors were centred by 
transforming to Z scores prior to calculation of the interactions. Neither of 
these interaction terms proved to be a significant predictor, and the model 
did not change in step 2.  
 
Internal consistency of the BASQID and its subscales was then calculated 
to eliminate the possibility that the observed association between patient 
QoL scores and insight might be due, in part, to differences in the 
reliability of the BASQID when it is used by patients with higher or lower 
levels of insight. This was not the case. A median split on the MARS-MFS 
discrepancy score was used to divide the sample into high (n=32) and low 
(n=37) insight groups and Cronbach’s alpha was calculated. The values of 
alpha were 0.88 and 0.92 respectively for the BASQID total score; 0.85 
and 0.87 for the LS subscale, and 0.82 and 0.87 for the FPQ subscale.  
 
 
Discussion 
 
The current study found a weak association between patient ratings of 
QoL, made using the BASQID, and proxy ratings measured by the ADRQL 
subscales. This finding supports previous research which suggests a clear 
disparity between patient and proxy measures of life quality. Significant 
predictors of patient QoL ratings were awareness of memory function (as 
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indicated by MARS-MFS discrepancy scores), proxy ratings of ADL function 
and the Enjoyment of Activities subscale within the ADRQL. In other 
words, patients with less insight about their own memory function, with 
better ADL ability and who exhibited more frequent displays of enjoyment 
were likely to report higher levels of QoL. Of these, awareness of memory 
function was found to be the strongest predictor.  
 
Whilst a relationship between patient QoL ratings and lack of insight has 
previously been proposed in the literature (Whitehouse, 1999), this study 
is the first to demonstrate the relationship empirically in people with mild 
dementia, using a rigorous measure of insight. We would argue that this 
contrasting finding serves only to confirm the multidimensional nature of 
insight in dementia and the related need to develop and apply rigorous 
domain-specific insight measures (Clare et al., 2002; Clare, 2004). 
Previous research on insight and QoL (Ready et al., 2004; Vogel et al., 
2006; Hurt et al., 2009) has approached insight through dichotomous or 
categorical global ratings, using mostly clinician judgements of the 
patient’s awareness. In contrast, the current study has employed the 
MARS-MSF which uses multiple ratings of specific behaviours provided by 
both patient and caregiver and focuses on a single aspect of insight, 
namely awareness of memory function.  
 
It becomes very tempting to interpret the QoL ratings of patients with 
lowered awareness as a simple case of ‘blissful ignorance’. If this were the 
whole story, however, lack of awareness of memory function should have 
emerged as the sole predictor of patient QoL ratings. It did not. ADL 
function and observable enjoyment of activities were also incorporated 
into those ratings and their respective associations with QoL were not 
moderated by memory awareness. This suggests a more complex 
situation in which some awareness of daily living activity and of 
enjoyment may remain intact even when awareness of memory function 
has effectively been lost.  
 
Brod et al.’s (1999) suggestion that awareness of feeling states may be 
distinct from awareness of cognitive function seems very relevant in this 
 12 
context. Whilst dementia patients may eventually lack direct awareness of 
their ADL function and performance, they may nonetheless retain 
awareness of the feelings these tasks elicit. The more functionally able 
they are, the more frequently they will engage in ADL, and the more 
opportunity they will have to experience positive feelings as a result. 
These feelings then form the basis of the patient’s own QoL assessments. 
The significant correlation observed between ADL function and enjoyment 
of activities in the current study supports this proposal. Further support is 
provided by the regression analyses for the BASQID subscales which show 
that ADL function is most strongly associated with a subscale (the FPQ) 
designed specifically to assess positive feelings (such as happiness, 
enjoyment, and self-efficacy) in the person with dementia.  
 
Our findings also demonstrate that changes in awareness of memory 
function may also mask the effects of changes in other outcomes such as 
ADL function. No significant correlation was found between ADL 
performance and patient QoL in this or several earlier studies (see also 
Logsdon et al., 2002; Hoe et al., 2007; Ready et al., 2004). However, 
when ADL scores were entered into a regression analysis alongside a 
measure of memory awareness, ADL function emerged as the second 
strongest predictor of patient life quality. This suggests that as dementia 
progresses, any reduction in QoL brought about by worsening ADL 
function may well be offset by improvements in QoL arising from a 
concurrent lack of insight about that function and its outcomes.    
 
These findings and observations have two major implications. Firstly, the 
potential masking effect suggests that some relevant measure of insight 
or awareness needs to be included in all batteries of assessment which 
target the well-being of dementia patients. This will be vital if the meaning 
of a change, or lack of change, in patient QoL measurements are to be 
correctly interpreted. It may indeed be particularly relevant to trials of 
pharmacological and therapeutic interventions, where improved patient 
function might otherwise be masked (and hence wrongly assumed to 
confer no QoL gain) if measurements are analysed in isolation or without 
consideration of the patient’s level of insight.  
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Secondly, it is important that the strong association between awareness of 
memory problems and patient QoL ratings revealed by the current study 
is not simply taken as evidence that patient QoL ratings are unreliable or 
uninformed. Reliability coefficients for all the BASQID scales remained 
stable above 0.8 across both high and low insight groups and whilst 
lowered awareness in a dementia patient tends to yield higher QoL ratings 
than those inferred by observation or proxy ratings, there is no reason to 
assume this occurs because of patient ignorance. On the contrary, we 
have seen that ADL function and enjoyment of activities are systematically 
incorporated in their QoL ratings.  
 
It seems more likely that the discrepancy between patient and proxy 
ratings occurs simply because two very distinct modes of QoL assessment, 
which emphasise very different outcomes, are being employed. Whilst 
observational or proxy ratings (and the measures through which they are 
gathered) commonly provide QoL judgements based upon an appraisal of 
the patient’s functional performance and their ability to ‘get the job done’, 
the dementia patient may be appraising the situation on the basis of the 
mood states and feelings the activity engendered. The two assessments 
may not even be directly comparable, an assertion which is supported by 
the traditionally low association of patient and proxy QoL measures. 
Indeed, in the context of more severe dementia, our findings suggest that 
awareness of memory function, ratings of ADL function and overt indices 
of enjoyment may supersede proxy QoL ratings as a surrogate measure of 
patient-perceived life quality. 
 
In conclusion, our data suggests that the decrements in awareness 
associated with dementia may ultimately lead a patient to a rejuvenated 
view of their life quality. It is important that such changes are 
acknowledged and recorded. Far from being ignorant (blissfully or 
otherwise), dementia patients may continue to base their QoL 
assessments on a rational appraisal of their current life circumstances 
which exploits all the information available to them. None of us could do 
more. These assessments may be feeling-centred but given an 
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appropriate measure of QoL they are still reliable. Judging the QoL of 
dementia patients solely on the basis of functional failure or in relation to 
proxy ratings is certainly convenient, but it may ultimately fail to capture 
or help us understand the experience of people with dementia. 
Understanding such experience will be vital if their life quality is to be 
maximised. 
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Table 1: Sample characteristics  
  Sample 
(n=69) 
Probable  Alzheimer’s / Mixed  54 (78%) 
diagnosis Vascular 7 (10%) 
 Frontotemporal 5 (7%) 
 Lewy Body 3 (5%) 
   
Cognitive ability MMSE mean (s.d.)  22.43 (2.44) 
 MMSE median (range) 23 (18-27) 
   
Sex Male 39 (57%) 
 Female 30 (43%) 
   
Age <65 3 (5%) 
 65-74 10 (14%) 
 75-85 49 (71%) 
 >85 7 (10%) 
   
Living arrangements Living alone 14 (20%) 
 Living with 
spouse/partner 
49 (71%) 
 Living with relative/other 6 (9%) 
   
Primary caregiver Spouse/partner 49 (71%) 
 Child 18 (27%) 
 Sibling 1 (1%) 
 Other relative 1 (1%) 
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Table 2: Descriptive statistics for BASQID, ADRQL, ADCS-ADL and MARS-MSF 
 n Mean SD Median Min Max 
 
BASQID total 69 60.38 14.49 57.14 21.43 96.43 
BASQID LS 69 57.07 14.89 56.25 18.75 93.75 
BASQID FPQ 
 
69 64.79 16.86 62.50 16.67 100.00 
ADRQL total 68 79.72 13.85 83.62 40.07 98.39 
ADRQL Social Interaction 69 82.64 16.94 86.07 26.47 100.00 
ADRQL Awareness of Self 69 75.24 15.72 77.21 34.23 100.00 
ADRQL Feelings and Mood 68 81.00 17.79 88.36 32.56 100.00 
ADRQL Enjoyment of 
Activities 
69 66.17 26.72 61.11 .00 100.00 
ADRQL Respond to 
Surroundings 
 
69 87.60 14.11 87.63 45.82 100.00 
ADCS-ADL  69 50.04 12.38 50.00 19.00 73.00 
MARS-MSF discrepancy 
scores 
69 20.16
  
11.27 21.00 -7.00 39.00 
BASQID = Bath Assessment of Subjective Quality of Life in Dementia; LS = Life 
Satisfaction; FPQ = Feelings of Positive Quality of Life; ADRQL = Alzheimer’s Disease-
Related Quality of Life Scale; ADCS-ADL = Alzheimer's Disease Cooperative Study 
Activities of Daily Living Inventory; MARS-MSF = Memory Functioning Scale  
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Table 3: Spearman Correlations between study variables 
 
 
 
 
BASQID 
Total 
BASQID 
LS 
BASQID 
FPQ 
ADRQL 
Total 
ADRQL 
Social 
Interaction 
ADRQL 
Awareness 
of Self 
ADRQL 
Feelings 
and 
Mood 
ADRQL 
Enjoyment 
of 
Activities 
ADRQL 
Respond to 
Surroundings 
ADCS-
ADL  
MARS-MSF 
discrepancy 
score 
BASQID LS .93**           
BASQID FPQ .91** .71**          
ADRQL .23 .18 .24*         
ADRQL Social 
Interaction 
.33** .32* .29* .78**        
ADRQL Awareness 
of Self 
-.04 -.04 -.07 .64** .49**       
ADRQL Feelings 
and Mood 
.17 .09 .23 .82** .58** .33**      
ADRQL Enjoyment 
of Activities 
.32** .26* .34** .66** .48** .26* .47**     
ADRQL Respond to 
Surroundings 
.11 .09 .13 .61** .29* .21 .47** .33**    
ADCS-ADL  .25* .15 .33** .38** .29* .23 .16 .36** .14   
MARS-MSF 
discrepancy 
score 
.31** .39** .19* -.19 -.03 -.10 -.12 -.18 -.12 -.45**  
MMSE  .05 .04 .08 .20 .05 .18 .02 .28* .17 .32* -.06 
BASQID = Bath Assessment of Subjective Quality of Life in Dementia; LS = Life Satisfaction; FPQ = Feelings of Positive Quality of Life; ADRQL = 
Alzheimer’s Disease-Related Quality of Life Scale; ADCS-ADL = Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory; MARS-MSF = 
Memory Functioning Scale; MMSE = Mini Mental State Examination  
** p<0.01 
* p<0.05 
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Table 4: Significant predictors of BASQID scale scores 
 
BASQID = Bath Assessment of Subjective Quality of Life in Dementia; LS = Life 
Satisfaction; FPQ = Feelings of Positive Quality of Life; ADRQL = Alzheimer’s Disease-
Related Quality of Life Scale; ADCS-ADL = Alzheimer's Disease Cooperative Study 
Activities of Daily Living Inventory; MARS-MSF = Memory Functioning Scale  
** p<0.01 
* p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BASQID BASQID LS BASQID FPQ 
 β (SE β)  β β (SE β)  β β (SE β)  β 
ADRQL Enjoyment 
of Activities 
0.16* (0.05) 0.29 0.13* (0.06) 0.25 0.18* (0.06) 0.29 
ADCS-ADL  0.46** (0.13) 0.39 0.36** (0.14) 0.30 0.60** (0.16) 0.43 
MARS-MSF 
discrepancy scores 
0.80** (0.13) 0.62 0.81** (0.14) 0.62 0.77** (0.16) 0.51 
Model % 43 37 38 
F =  16.01 12.48 13.26 
P ≤ 0.001 0.001 0.001 
Adjusted R2 0.40 0.34 0.35 
